东海证券给予国际医学买入评级：诊疗量增长稳健，收入短期承压

Group 1 - Donghai Securities issued a report on August 27, giving a "buy" rating to International Medical (000516.SZ, latest price: 5.47 yuan) [1] - The rating rationale includes short-term revenue pressure with expected improvement in Q2 2025 [1] - High-tech hospitals are maintaining stable diagnosis and treatment volumes [1] - Central hospitals are experiencing steady growth in business scale, with the proton center expected to be operational within the year [1]